ATE182901T1 - Für androgen-rezeptor-protein kodierende dna - Google Patents
Für androgen-rezeptor-protein kodierende dnaInfo
- Publication number
- ATE182901T1 ATE182901T1 AT89905317T AT89905317T ATE182901T1 AT E182901 T1 ATE182901 T1 AT E182901T1 AT 89905317 T AT89905317 T AT 89905317T AT 89905317 T AT89905317 T AT 89905317T AT E182901 T1 ATE182901 T1 AT E182901T1
- Authority
- AT
- Austria
- Prior art keywords
- receptor protein
- androgen receptor
- dna coding
- human androgen
- polypeptides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2869—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against hormone receptors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
- C07K14/721—Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/182,646 US6307030B1 (en) | 1988-04-15 | 1988-04-15 | Androgen receptor proteins, recombinant DNA molecules coding for such, and use of such compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE182901T1 true ATE182901T1 (de) | 1999-08-15 |
Family
ID=22669419
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT89905317T ATE182901T1 (de) | 1988-04-15 | 1989-04-13 | Für androgen-rezeptor-protein kodierende dna |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US6307030B1 (de) |
| EP (1) | EP0365657B1 (de) |
| JP (1) | JP3385380B2 (de) |
| AT (1) | ATE182901T1 (de) |
| CA (1) | CA1341347C (de) |
| DE (1) | DE68929043T2 (de) |
| WO (1) | WO1989009791A1 (de) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5614620A (en) * | 1988-03-30 | 1997-03-25 | Arch Development Corporation | DNA binding proteins including androgen receptor |
| US6307030B1 (en) | 1988-04-15 | 2001-10-23 | The University Of North Carolina At Chapel Hill | Androgen receptor proteins, recombinant DNA molecules coding for such, and use of such compositions |
| EP0505387A4 (en) * | 1989-11-17 | 1993-06-30 | Arch Development Corporation | Dna binding proteins including androgen receptor |
| WO1997011170A1 (en) * | 1995-09-20 | 1997-03-27 | Worcester Foundation For Biomedical Research | Antisense oligonucleotide chemotherapy for benign hyperplasia or cancer of the prostate |
| WO1998011139A1 (en) * | 1996-09-11 | 1998-03-19 | Oregon Health Sciences University | Small and intermediate conductance, calcium-activated potassium channels and uses thereof |
| AU4494399A (en) * | 1998-06-30 | 2000-01-24 | University Of British Columbia, The | Inhibitors of androgen-independent activation of androgen receptor |
| DE19834180A1 (de) | 1998-07-29 | 2000-02-03 | Benckiser Nv | Zusammensetzung zur Verwendung in einer Geschirrspülmaschine |
| CA2446819A1 (en) | 2001-05-08 | 2002-11-14 | Merck & Co., Inc. | Dna molecules encoding macaca mulatta androgen receptor |
| WO2003012394A2 (en) * | 2001-07-27 | 2003-02-13 | University Of Rochester | Androgen receptor knock-out transgenic animals |
| EP1487965A4 (de) | 2002-02-25 | 2006-11-15 | Mpex Pharmaceuticals Inc | Minizellzusammensetzungen und -verfahren |
| US20070141568A1 (en) * | 2002-12-20 | 2007-06-21 | Biodetection Systems B.V. | Method for determining the presence of one or more ligands in a sample |
| US7467119B2 (en) * | 2003-07-21 | 2008-12-16 | Aureon Laboratories, Inc. | Systems and methods for treating, diagnosing and predicting the occurrence of a medical condition |
| US7483554B2 (en) * | 2003-11-17 | 2009-01-27 | Aureon Laboratories, Inc. | Pathological tissue mapping |
| US7505948B2 (en) * | 2003-11-18 | 2009-03-17 | Aureon Laboratories, Inc. | Support vector regression for censored data |
| DE602004031881D1 (de) * | 2003-12-19 | 2011-04-28 | Univ California | Verfahren und materialien zur beurteilung von prostatakrebstherapien |
| US7718684B2 (en) | 2004-02-24 | 2010-05-18 | The Regents Of The University Of California | Methods and materials for assessing prostate cancer therapies and compounds |
| TW200532523A (en) * | 2004-02-27 | 2005-10-01 | Aureon Biosciences Corp | Methods and systems for predicting occurrence of an event |
| WO2006020627A1 (en) * | 2004-08-11 | 2006-02-23 | Aureon Laboratories, Inc. | Systems and methods for automated diagnosis and grading of tissue images |
| US7709517B2 (en) * | 2005-05-13 | 2010-05-04 | The Regents Of The University Of California | Diarylhydantoin compounds |
| KR100777082B1 (ko) | 2005-08-30 | 2007-11-28 | 주식회사 엘지생활건강 | 올리고뉴클레오타이드를 포함하는 피지분비 억제용 화장료조성물 |
| EP2656842B1 (de) | 2006-03-27 | 2016-08-10 | The Regents of The University of California | Androgenrezeptor-modulator zur behandlung von prostatakrebs und androgenrezeptor-assoziierte erkrankungen |
| WO2007127010A2 (en) * | 2006-03-29 | 2007-11-08 | The Regents Of The University Of California | Diarylthiohydantoin compounds |
| WO2007136837A2 (en) * | 2006-05-19 | 2007-11-29 | University Of Rochester | Prostate epithelial androgen receptor suppresses prostate growth and tumor invasion |
| US7910565B2 (en) * | 2006-09-01 | 2011-03-22 | Wisconsin Alumni Research Foundation | Prostate cancer vaccine |
| CA2681917A1 (en) * | 2007-03-27 | 2008-10-02 | Christopher Hovens | Methods and compositions for treating prostate cancer |
| CA2966280A1 (en) | 2007-10-26 | 2009-04-30 | The Regents Of The University Of California | Diarylhydantoin compounds |
| CA2733506A1 (en) * | 2008-08-08 | 2010-02-11 | Christopher Hovens | Biological applications of steroid binding domains |
| US8133724B2 (en) * | 2008-09-17 | 2012-03-13 | University Of Maryland, Baltimore | Human androgen receptor alternative splice variants as biomarkers and therapeutic targets |
| US8841422B2 (en) | 2008-09-17 | 2014-09-23 | University Of Maryland, Baltimore | Human androgen receptor alternative splice variants |
| GB0921873D0 (en) * | 2009-12-15 | 2010-01-27 | Cytosystems Ltd | Assay |
| HUE037389T2 (hu) | 2010-02-16 | 2018-08-28 | Aragon Pharmaceuticals Inc | Androgén receptor modulátorok és alkalmazásaik |
| ES2836424T3 (es) | 2012-09-26 | 2021-06-25 | Aragon Pharmaceuticals Inc | Antiandrógenos para tratar el cáncer de próstata no metastásico y resistente a la castración |
| CA3105575A1 (en) | 2013-01-15 | 2014-07-24 | Aragon Pharmaceuticals, Inc. | Androgen receptor modulator and uses thereof |
| JP6668255B2 (ja) * | 2014-04-30 | 2020-03-25 | エクスプレッション、パソロジー、インコーポレイテッドExpression Pathology, Inc. | アンドロゲン受容体(ar)タンパク質のsrm/mrmアッセイ |
| TWI726969B (zh) | 2016-01-11 | 2021-05-11 | 比利時商健生藥品公司 | 用作雄性激素受體拮抗劑之經取代之硫尿囊素衍生物 |
| UA129105C2 (uk) | 2017-10-16 | 2025-01-15 | Арагон Фармасьютикалз, Інк. | Антиандрогени для лікування неметастатичного резистентного до кастрації раку передміхурової залози |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4423208A (en) | 1982-02-24 | 1983-12-27 | Peter Grandics | Affinity gel-adsorbent |
| JPS63502397A (ja) | 1986-02-20 | 1988-09-14 | カロビオ エービー | ステロイドレセプタ−タンパクの真核細胞における発現 |
| US5614620A (en) * | 1988-03-30 | 1997-03-25 | Arch Development Corporation | DNA binding proteins including androgen receptor |
| EP0407462A4 (en) | 1988-03-30 | 1992-02-05 | Arch Development Corporation | Dna binding proteins including androgen receptor |
| US6307030B1 (en) | 1988-04-15 | 2001-10-23 | The University Of North Carolina At Chapel Hill | Androgen receptor proteins, recombinant DNA molecules coding for such, and use of such compositions |
-
1988
- 1988-04-15 US US07/182,646 patent/US6307030B1/en not_active Expired - Fee Related
-
1989
- 1989-04-13 AT AT89905317T patent/ATE182901T1/de not_active IP Right Cessation
- 1989-04-13 DE DE68929043T patent/DE68929043T2/de not_active Expired - Lifetime
- 1989-04-13 JP JP50503989A patent/JP3385380B2/ja not_active Expired - Lifetime
- 1989-04-13 WO PCT/US1989/001548 patent/WO1989009791A1/en not_active Ceased
- 1989-04-13 EP EP89905317A patent/EP0365657B1/de not_active Expired - Lifetime
- 1989-04-14 CA CA000596763A patent/CA1341347C/en not_active Expired - Fee Related
-
2000
- 2000-02-03 US US09/497,822 patent/US6821767B1/en not_active Expired - Fee Related
-
2004
- 2004-07-07 US US10/886,384 patent/US7129078B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP3385380B2 (ja) | 2003-03-10 |
| US6821767B1 (en) | 2004-11-23 |
| EP0365657A4 (en) | 1991-08-21 |
| EP0365657A1 (de) | 1990-05-02 |
| US7129078B2 (en) | 2006-10-31 |
| JPH03500605A (ja) | 1991-02-14 |
| WO1989009791A1 (en) | 1989-10-19 |
| US20050079576A1 (en) | 2005-04-14 |
| CA1341347C (en) | 2002-03-12 |
| US6307030B1 (en) | 2001-10-23 |
| DE68929043T2 (de) | 2000-04-13 |
| DE68929043D1 (de) | 1999-09-09 |
| EP0365657B1 (de) | 1999-08-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE182901T1 (de) | Für androgen-rezeptor-protein kodierende dna | |
| DE68926888D1 (de) | Verfahren zur Herstellung von sekretierten Rezeptoranalogen | |
| UA39161C2 (uk) | Рекомбінантний білок gm-csf для збільшення продукції гранулоцитів і макрофагів у пацієнтів, вектор і кднк, що його кодують | |
| PT93910A (pt) | Prodesso para a preparacao de uma proteina heterologa mediante secrecao a partir de uma celula | |
| PT101297A (pt) | Factores mitogenicos gliais, sua preparacao e utilizacao | |
| ATE319818T1 (de) | Polypeptide mit aminopeptidaseaktivität und für diese kodierende nukleinsäuren | |
| ATE352559T1 (de) | Verfahren zur verminderung der immunogenität von proteinen | |
| ATE388165T1 (de) | Menschliches cnp-gen und vorläuferprotein | |
| HUT46061A (en) | Dna sequences encoding hirudin-like protein and process for producing such proteins | |
| DE69637874D1 (de) | C-C CHEMOKIN REZEPTOR 3: CKR-3 ODER Eos-L2 | |
| NO892033D0 (no) | Fibronectinbindende protein. | |
| BG104266A (en) | Aminoterminally incised mcp-2 as haemokin antagonists | |
| IS2819B (is) | Viðloðunarsameindir í æðum og mótun á starfsemi@þeirra | |
| ATE358725T1 (de) | Polypeptide mit aminopeptidaseaktivität und dafür kodierende nukleinsäuren | |
| PT84089A (en) | Dna sequences coding for proteins having the biological activity of husi-type i inhibitors biotechnological methods for the preparation of said proteins and pharmaceutical compositions containing said proteins | |
| DE3881023D1 (de) | Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten. | |
| NO930428D0 (no) | Proteinstrukturen til plantetoksingelonin | |
| HUP0001057A2 (hu) | A szarvasmarhafélék laktációjával összefüggő fehérje (CD14), az azt kódoló gén és a fehérje B-sejt-aktiválásban való alkalmazása | |
| DK595187A (da) | Minactivin og fremgangsmaade til fremstilling deraf | |
| AU5327198A (en) | Nucleotide sequence coding for a flavin-containing monooxygenase, corresponding protein and their applications in the fields of diagnosis and therapy | |
| HUP0004739A1 (hu) | Presenilinekkel kölcsönhatásra képes fehérjéket kódoló nukleinsavak | |
| DE69033553D1 (de) | Rekombinante herstellung von laktoperoxidase | |
| DE60231816D1 (de) | Menschliche alpha2-delta4-calciumkanal-untereinheit codierende cdna | |
| NZ510812A (en) | Novel peptides | |
| AU4956901A (en) | Novel human 7tm proteins and polynucleotides encoding the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |